86 related articles for article (PubMed ID: 8508351)
1. Genotypic classification of colorectal adenocarcinoma. Biologic behavior correlates with K-ras-2 mutation type.
Finkelstein SD; Sayegh R; Christensen S; Swalsky PA
Cancer; 1993 Jun; 71(12):3827-38. PubMed ID: 8508351
[TBL] [Abstract][Full Text] [Related]
2. Variation in K-ras codon 12 point mutation rate with histological atypia within individual colorectal tumors.
Soh K; Yanagisawa A; Hiratsuka H; Sugano H; Kato Y
Jpn J Cancer Res; 1993 Apr; 84(4):388-93. PubMed ID: 8514605
[TBL] [Abstract][Full Text] [Related]
3. Transcriptomic Differences between Primary Colorectal Adenocarcinomas and Distant Metastases Reveal Metastatic Colorectal Cancer Subtypes.
Kamal Y; Schmit SL; Hoehn HJ; Amos CI; Frost HR
Cancer Res; 2019 Aug; 79(16):4227-4241. PubMed ID: 31239274
[TBL] [Abstract][Full Text] [Related]
4. Identification of a Tumor Specific, Active-Site Mutation in Casein Kinase 1α by Chemical Proteomics.
Okerberg ES; Hainley A; Brown H; Aban A; Alemayehu S; Shih A; Wu J; Patricelli MP; Kozarich JW; Nomanbhoy T; Rosenblum JS
PLoS One; 2016; 11(3):e0152934. PubMed ID: 27031502
[TBL] [Abstract][Full Text] [Related]
5. Survival Outcomes in Stage IV Gastric Cancer Patients with Krukenberg Tumors: A Systematic Review and Meta Analysis.
Anwar J; Abdelhakeem A; Khan MS; Arslan HM; Shuroog J; Sarfraz Z; Saeed A; Saeed A
J Gastrointest Cancer; 2024 May; ():. PubMed ID: 38748352
[TBL] [Abstract][Full Text] [Related]
6. Assessment of Primary Colorectal Cancer CT Radiomics to Predict Metachronous Liver Metastasis.
Li Y; Gong J; Shen X; Li M; Zhang H; Feng F; Tong T
Front Oncol; 2022; 12():861892. PubMed ID: 35296011
[TBL] [Abstract][Full Text] [Related]
7. Not All Kirsten Rat Sarcoma Viral Oncogene Homolog Mutations Predict Poor Survival in Patients With Unresectable Colorectal Liver Metastasis.
Lin Z; Liu Y; Cai S; Yang C; Zhou L; Li W
Technol Cancer Res Treat; 2021; 20():15330338211039131. PubMed ID: 34669528
[No Abstract] [Full Text] [Related]
8. Discovery of a novel and a rare Kristen rat sarcoma viral oncogene homolog (KRAS) gene mutation in colorectal cancer patients.
Rasool M; Carracedo A; Sibiany A; Al-Sayes F; Karim S; Haque A; Natesan Pushparaj P; Asif M; Achakzai NM
Bioengineered; 2021 Dec; 12(1):5099-5109. PubMed ID: 34369256
[TBL] [Abstract][Full Text] [Related]
9. Copy Number Variation and Rearrangements Assessment in Cancer: Comparison of Droplet Digital PCR with the Current Approaches.
Cusenza VY; Bisagni A; Rinaldini M; Cattani C; Frazzi R
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946969
[TBL] [Abstract][Full Text] [Related]
10. A Pterin-FAM-TAMRA Tri-color Fluorescence Biosensor to Detect the Level of KRAS Point Mutation.
Zeng N; Guo Y; Xiang J
Anal Sci; 2020 Dec; 36(12):1529-1533. PubMed ID: 32830162
[TBL] [Abstract][Full Text] [Related]
11. Association of KRAS mutation with tumor deposit status and overall survival of colorectal cancer.
Zhang M; Hu W; Hu K; Lin Y; Feng Z; Yun JP; Gao N; Zhang L
Cancer Causes Control; 2020 Jul; 31(7):683-689. PubMed ID: 32394229
[TBL] [Abstract][Full Text] [Related]
12. Isoform-Specific Destabilization of the Active Site Reveals a Molecular Mechanism of Intrinsic Activation of KRas G13D.
Johnson CW; Lin YJ; Reid D; Parker J; Pavlopoulos S; Dischinger P; Graveel C; Aguirre AJ; Steensma M; Haigis KM; Mattos C
Cell Rep; 2019 Aug; 28(6):1538-1550.e7. PubMed ID: 31390567
[TBL] [Abstract][Full Text] [Related]
13. Examination of Hypoxanthine Guanine Phosphoribosyltransferase as a biomarker for colorectal cancer patients.
Townsend MH; Felsted AM; Burrup W; Robison RA; O'Neill KL
Mol Cell Oncol; 2018; 5(4):e1481810. PubMed ID: 30250925
[TBL] [Abstract][Full Text] [Related]
14. RAS testing in metastatic colorectal cancer: advances in Europe.
Van Krieken JH; Rouleau E; Ligtenberg MJ; Normanno N; Patterson SD; Jung A
Virchows Arch; 2016 Apr; 468(4):383-96. PubMed ID: 26573425
[TBL] [Abstract][Full Text] [Related]
15. Association Between Specific Mutations in KRAS Codon 12 and Colorectal Liver Metastasis.
Margonis GA; Kim Y; Spolverato G; Ejaz A; Gupta R; Cosgrove D; Anders R; Karagkounis G; Choti MA; Pawlik TM
JAMA Surg; 2015 Aug; 150(8):722-9. PubMed ID: 26038887
[TBL] [Abstract][Full Text] [Related]
16. Factors Associated With Guideline-recommended KRAS Testing in Colorectal Cancer Patients: A Population-based Study.
Charlton ME; Karlitz JJ; Schlichting JA; Chen VW; Lynch CF
Am J Clin Oncol; 2017 Oct; 40(5):498-506. PubMed ID: 25844824
[TBL] [Abstract][Full Text] [Related]
17. Concordant analysis of KRAS, BRAF, PIK3CA mutations, and PTEN expression between primary colorectal cancer and matched metastases.
Mao C; Wu XY; Yang ZY; Threapleton DE; Yuan JQ; Yu YY; Tang JL
Sci Rep; 2015 Feb; 5():8065. PubMed ID: 25639985
[TBL] [Abstract][Full Text] [Related]
18. Differential reprogramming of isogenic colorectal cancer cells by distinct activating KRAS mutations.
Hammond DE; Mageean CJ; Rusilowicz EV; Wickenden JA; Clague MJ; Prior IA
J Proteome Res; 2015 Mar; 14(3):1535-46. PubMed ID: 25599653
[TBL] [Abstract][Full Text] [Related]
19. Pragmatic issues in biomarker evaluation for targeted therapies in cancer.
de Gramont A; Watson S; Ellis LM; Rodón J; Tabernero J; de Gramont A; Hamilton SR
Nat Rev Clin Oncol; 2015 Apr; 12(4):197-212. PubMed ID: 25421275
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
